250
Participants
Start Date
April 30, 2004
Primary Completion Date
October 31, 2007
Study Completion Date
October 31, 2007
zoledronic acid
Taxotere
Carboplatin
Arena Oncology Assoc., Great Neck
Engracio Cortes, MD, Bayside
SUNY Upstate Medical University, Syracuse
Syracuse VA Medical Center, Syracuse
James P. Wilmot Cancer Center, Rochester
Oncology Care Associates, Bethesda
Masoom Kandahari, MD, Woodbridge
Odyssey Research, Belle Haven
West Virginia University, Morgantown
Knoxville Cancer Center, Knoxville
Presbyterian Hospital, Charlotte
Southern Oncology Research, Grifton
Santee Hematology/Oncology, Sumter
Liberty Hematology-Oncology, Columbia
Charleston Hematology Oncology, Charleston
Charleston Cancer Center, Charleston
Peachtree Hematology & Oncology, Atlanta
Emory University, Atlanta
Metcare Oncology, Ormond Beach
Hematology-Oncology Associates, Pensacola
VA Medical Center, Miami
Innovative Medical Research of South Florida, Inc., Miami Shores
Lynn Regional Cancer Center, Boca Raton
AMIT SHAH Medical Group, Sebring
NCH Healthcare System Oncology Research, Naples
New Hope Cancer Centers, Hudson
Oceola Cancer Center, Kissimmee
Clinical Research Consultants, Hoover
The Jones Clinic, Germantown
Barberton Citizens Hospital-Cancer Center, Barberton
Forum Health Cancer CareCenter, Youngstown
Dayton Clinical Oncology Program, Dayton
Central Indiana Cancer Centers, Indianapolis
Community Hospital, Cancer Research Dept., Munster
Northern Indiana Oncology Associates, South Bend
Oncology Institute of Greater Lafayette, Lafayette
Mitchell Folbe, MD, PC, Troy
Karmanos Cancer Institute, Detroit
Kalamazoo Hematology & Oncology, Kalamazoo
Cedar Valley Medical Specialists, Waterloo
Park Nicollett Institute, Saint Louis Park
Advocate Illinois Masonic Medical Center Creticos Cancer Center, Chicago
OSF Center for Cancer Care, Rockford
Springfield Clinic, LLP, Springfield
St. Louis Cancer Care, Chesterfield
Kansas City Cancer Ctr. South, Lenexa
Southeast Nebraska Cancer Center, Lincoln
Odyssey Research, Scottsbluff
Hematology/Oncology Clinic, Baton Rouge
Mary Bird Perkins Cancer Center, Baton Rouge
LSU Health Sciences Center, Shreveport
NEA Clinic, Jonesboro
Highlands Oncology Group, Springdale
Cancer Specialists of Oklahoma, Oklahoma City
Blood and Cancer Center of East Texas, Tyler
Tyler Hematology Oncology, PA, Tyler
Cancer Specialists of South Texas, Corpus Christi
Northern Hematology-Oncology, Thornton
Cancer Center of Colorado Springs, Colorado Springs
Arizona Oncology Assoc., Tucson
New Mexico Oncology Hematology Consultants, Ltd., Albuquerque
San Juan Regional Cancer Ctr., Farmington
New Mexico Cancer Care Associates, Santa Fe
Southern Nevada Cancer Research Foundation, Las Vegas
Nevada Cancer Center, Las Vegas
Clinical Trials and Research Associates, Inc., Montebello
UCLA, Los Angeles
Med. Oncology Care Associates, Orange
Cancer Center of Santa Barbara, Santa Barbara
NorthBay Cancer Center, Fairfield
Straub Clinic & Hospital, Honolulu
Kaiser Foundation Hospital, Honolulu
Hematology Oncology Associates, Medford
Maine Center for Cancer Medicine, Scarborough
Berkshire Hematology Oncology PC, Pittsfield
East Orange VA Medical System, East Orange
Howell Office Plaza, Howell Township
Atlantic Hem Onc Associates, LLC, Manasquan
Hematology/Oncology Assoc. of South Jersey, Mount Holly
Cancer Institute of New Jersey at Cooper University Hospital, Voorhees Township
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY